Compare Banco Santander SA (SAN) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Banco Santander SA vs Tempus AI — how do they compare? Banco Santander SA trades at $13.5 (market cap $192.86B), while Tempus AI trades at $71 (market cap $12.58B). The key difference: Banco Santander SA is far larger — about 15.3× Tempus AI's market cap, and Banco Santander SA pays a 2.06% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Banco Santander SA for 55 Days and Tempus AI for 23 Days on average.
| SAN | TEM | |
|---|---|---|
Market Cap | $192.86B | $12.58B |
Volume | 10,644,519 | 7,444,569 |
Sector | Financials | Broad Market / Factor |
52-Week High | $15.05 | $99.28 |
52-Week Low | $9.65 | $41.55 |
Typical Hold Time | 55 Days | 23 Days |
Enterprise Value | $360.86B | $13.21B |
Dividend Yield | 2.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Banco Santander (SAN) trades at $13.49, down 1.24% with bearish technical signals, though fundamentals show strength with 26.25% net margins and 16.07% ROE. Recent earnings show mixed quarterly performance, beating in Q1 but missing in Q2. The company completed the Webster Bank acquisition in August 2026, expanding U.S. presence and driving record profits. Cash flow trends remain negative, but revenue and net income have grown steadily from 2022-2026.
Outlook remains cautiously optimistic with 64% analyst buy ratings supporting growth potential from strategic acquisitions and digital transformation. Key risks include negative cash flow trends, high debt levels at $288B, and economic sensitivity. The stock offers value at 13.55 P/E but requires monitoring of operational cash flow recovery and integration of recent acquisitions.
Tempus AI (TEM) trades at $71.46, up 1.66% with a bullish technical signal despite negative profitability metrics. The stock shows strong analyst support with 9 buy ratings and a $72.60 consensus target. Recent FDA clearance for ECG-MR AI product and 13 ESMO Congress presentations highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist at -$254M.
Outlook remains cautiously optimistic given strong institutional backing and AI healthcare growth potential, but profitability challenges and insider selling present near-term risks. The stock's valuation appears stretched with P/S of 8.61 and P/B of 28.27, requiring sustained revenue acceleration to justify current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Banco Santander SA
Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
